{"count": 1, "results": [{"_id": "36495080", "pmid": 36495080, "title": "First report of oral atenolol for treatment of kaposiform hemangioendothelioma, a viable alternative to propranolol.", "journal": "J Dermatol", "authors": ["Yu L", "Wei L", "Ma L", "Li L"], "date": "2022-12-10T00:00:00Z", "doi": "10.1111/1346-8138.16657", "meta_date_publication": "2022 Dec 10", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50286.703, "text_hl": "First report of oral @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ for treatment of @<m>DISEASE_Kaposiform_Hemangioendothelioma</m> @DISEASE_MESH:C537007 @@@kaposiform hemangioendothelioma@@@, a viable alternative to @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@.", "citations": {"NLM": "Yu L, Wei L, Ma L, Li L. First report of oral atenolol for treatment of kaposiform hemangioendothelioma, a viable alternative to propranolol. J Dermatol. 2022 Dec 10;():. PMID: 36495080", "BibTeX": "@article{36495080, title={First report of oral atenolol for treatment of kaposiform hemangioendothelioma, a viable alternative to propranolol.}, author={Yu L and Wei L and Ma L and Li L}, journal={J Dermatol}}"}}]}